📋 Medicare 2027 Drug Price Negotiations List Announced (AARP Article)

[Winter2025VA]

FROM THE ARTICLE.

Second Round of Medicare-Negotiated Price Cuts Expected to Save Billions in Drug Costs in 2027.

Newly announced savings on 15 high-cost medications include popular Ozempic family of weight-loss drugs.

By Tony Pugh, AARP. Published November 25, 2025.

Key takeaways!

(1) 5.3 million on Medicare use these medicines, will benefit.

(2) Second round of price reductions debut in 2027.

(3) Medicare will spend a lot less on Ozempic family of meds.

(4) Another 15 drugs will be selected for 2028, 20 for 2029.

(5) High medication costs are high priority for older adults.

Fifteen additional expensive and widely used prescription drugs will have lower negotiated prices for Medicare beneficiaries in 2027, the federal government announced late Tuesday.

About 5.3 million beneficiaries use these medications, which account for $40.7 billion in Medicare Part D spending, to treat common conditions such as asthma, cancer, chronic obstructive pulmonary disease (COPD) and diabetes.

USE LINK BELOW TO READ THE ARTICLE.

https://www.aarp.org/medicare/medicare-2027-drug-price-negotiations-list/